Skip to content

Change in AR at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$595M-35.7%
Amgen logo
AmgenAMGN
-$413M-132%
TG Therapeutics logo
TG TherapeuticsTGTX
$86.42M+41.8%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
-$563K-562%
Biogen logo
BiogenBIIB
-$25.68M+53.8%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$1.2M+99.8%

Other financials

Income statement

See full
Revenue$396.0K-81.8%
Operating income-$46.5M-40.3%
Net income-$40.8M-38.4%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$627.7M+6,105%
Total debt$1.4M-2.3%
Total equity$1.2B+266%
Total assets$1.2B+258%

Cash flow

See full
Operating cash flow-$28.9M-4.4%
CapEx$10.0K-58.3%
Free cash flow-$28.9M-4.4%

Valuation

See full
Market cap$4.51B+662%

Profitability

See full
Operating margin-4,558.4%-9,354pp
Net margin-4,104.8%-7,304pp
FCF margin-3,561.6%-6,956pp

Returns & leverage

See full
Return on equity-28.6%+3.2pp
Debt / equity0.0×
Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dianthus Therapeutics's change in AR?
Dianthus Therapeutics (DNTH) reported change in AR of $1.18M in Q1 2026.
How has Dianthus Therapeutics's change in AR changed year-over-year?
Dianthus Therapeutics's change in AR increased by 17.8% year-over-year, from $1M to $1.18M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.